CGP-47969A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCGP-47969A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 alpha inhibitorsInterleukin-6 inhibitorsTumor necrosis factor inhibitors +[4] 
TargetsTumor necrosis factorInterleukin-1 alphaInterleukin-1 beta +[4] 
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRheumatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A